Strata Oncology Stock
Strata Oncology is a precision oncology company dedicated to transforming cancer care.
Sign up today and learn more about Strata Oncology Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Strata Oncology Stock
Strata Oncology is a precision oncology company dedicated to transforming cancer care by expanding patient access to precision medicine clinical trials and accelerating drug approval. Strata's national precision oncology platform serves the needs of patients, providers and drug developers by providing a link from patient screening to streamlined enrollment in mutation-matched clinical trials. Follow us on Twitter @StrataOncology.
Investors
Baird Capital
Wellington Capital Management
Pfizer Venture Investments
Funding History
| June 2016 | $12.0M |
|---|---|
| May 2018 | $26.0M |
| July 2021 | $90.0M |
Management
Co-founder & CEO
Dan Rhodes
Chief Medical Officer, Co-Founder
Scott Tomlins
Chief Financial Officer
Matt Martin
Vice President Clinical Operations
Kat Kwiatkowski
Board of Directors (Observer)
David Gregorka
Board Member, Investor
Jan Garfinkle
Board of Director
Keith Flaherty
Board Member
Nicole Walker
Press
patents - Apr, 13 2024
Cancer biomarkers for immune checkpoint inhibitorspatents - Apr, 13 2024
Methods for identifying mutations using machine learningpatents - Apr, 13 2024
Methods of detecting ntrk fusion proteinsprnewswire - Mar, 1 2024
Strata Oncology Announces Appointment of Goz Alhir as Senior Vice President of Commercializationkalkinemedia - Mar, 1 2024
Precision Oncology Market to Capture a CAGR of 11.7%, Expected To Reach $166.97 Billion by 2030 | IMREquityZen Recognized As:
